NIH-funded research R01 grant

How COVID-19 affects people living with HIV/AIDS

Official title: Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS

Funded at Texas Biomedical Research Institute · NIH-11019828 · Data updated 2026-11-12

This study is looking at how COVID-19 affects people living with HIV/AIDS by using monkey models to see if having HIV makes COVID-19 worse, and it aims to understand the immune responses involved to help improve care for those affected.

More COVID-19 research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTexas Biomedical Research Institute
NIH-funded
Lab location1 site (San Antonio, United States)
Project startFebruary 1, 2022
Project endJanuary 31, 2027
Funding year2025
Award (this year)$934,853
NIH project number5R01AI170197-04
Project IDNIH-11019828 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV/AIDS who may be at risk for severe COVID-19 outcomes.

Less likely to help

Patients who do not have HIV/AIDS or those who are not at risk for severe COVID-19 may not benefit from this research.

What this research studies

This research investigates the impact of COVID-19 on individuals living with HIV/AIDS by utilizing rhesus macaque models to understand the relationship between SIV infection and the severity of COVID-19. The study aims to characterize how underlying HIV infection may lead to worse outcomes in COVID-19 cases, particularly focusing on both acute and post-acute effects. By examining the immune responses in these models, the research seeks to uncover the mechanisms that contribute to increased vulnerability in this population.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies and preventive measures for people living with HIV/AIDS who contract COVID-19.

How similar studies have gone: Previous research has shown that understanding co-morbidities in infectious diseases can lead to significant advancements in treatment, indicating potential success for this approach.

Where this research is happening

  • Texas Biomedical Research Institute
    San Antonio, United States
    Active

Researchers

  • Principal investigator: Singh, Dhiraj Kumar — Texas Biomedical Research Institute
  • Study coordinator: Singh, Dhiraj Kumar

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.